Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.7%

1 terminated out of 37 trials

Success Rate

95.0%

+8.5% vs benchmark

Late-Stage Pipeline

19%

7 trials in Phase 3/4

Results Transparency

11%

2 of 19 completed with results

Key Signals

2 with results95% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (14)
P 3 (2)
P 4 (5)

Trial Status

Completed19
Unknown9
Recruiting7
Terminated1
Withdrawn1

Trial Success Rate

95.0%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT02578810RecruitingPrimary

PIERS and BIS, sFIT:PIGF, Adrenomedullin

NCT06281665Phase 4Recruiting

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06069102Phase 4Completed

Optimal Blood Pressure Treatment Thresholds Postpartum

NCT06997575Phase 4CompletedPrimary

Comparing Intravenous and Intramuscular Magnesium Sulphate for Preventing Seizure Recurrence in Women With Eclampsia

NCT01736826Completed

Free DNA and Nucleosome Concentrations in Pathological Pregnancies

NCT05655936Not ApplicableRecruiting

Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial

NCT07151339Recruiting

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

NCT06523569Not ApplicableRecruiting

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

NCT05678062Not ApplicableRecruitingPrimary

Point-of-care Ultrasound Abnormalities in Eclampsia

NCT06377878Recruiting

The Preeclampsia Registry

NCT06219109UnknownPrimary

Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia

NCT03978429Not ApplicableCompleted

An mHealth Strategy to Reduce Pre-Eclampsia and Infant Death in Tanzania

NCT06126068Not ApplicableCompleted

Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia.

NCT02911701Phase 4Completed

Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features

NCT04998942Not ApplicableUnknown

Virtual Cardiac Wellness Program Following Hypertensive Disorders of Pregnancy

NCT05121415Completed

Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy

NCT03455387Completed

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

NCT04855513Not ApplicableUnknown

Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial

NCT02351583Withdrawn

Microcirculatory and Tissue and Cerebral Oxygenation in Preeclampsia and Normal Pregnancy: An Observation Study

NCT05143710Completed

The Clinical and Prognostic Features of PRES

Scroll to load more

Research Network

Activity Timeline